Instrument Inactif

Autres langues AVAX Technologies, Inc. Other OTC

Actions

27/01/16	Avax Technologies Announces Results of its OVAX, Ovarian Cancer Vaccine, Phase 1/2 Clinical Trial in Patients with Relapsed Stage III or IV Ovarian Cancer
19/10/15	AVAX Technologies, Inc. Appoints Adele Sommerfeld as Chief Executive Officer
19/10/15	AVAX Technologies : Announces the Appointment of Chief Executive Officer
04/08/15	AVAX Technologies Inc. announced that it expects to receive $45 million in funding
11/02/14	AVAX Technologies Inc. Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine Ovax
16/12/09	AVAX TEC : AVAX Technologies, Inc. Closes Bridge Financing
30/11/-1	AVAX TECHNOLOGIES : AVAX Technologies, Inc. Announces Closing of Bridge Loan Financing